The ongoing impact of COVID-19 extends far beyond the initial acute infection, with a significant number of individuals experiencing persistent symptoms—a condition known as long COVID. Emerging research is now focusing on whether pre-existing health conditions, specifically HIV, influence the likelihood or severity of developing long COVID. A recent report from Medscape highlights growing evidence suggesting that people living with HIV may face a heightened risk of experiencing prolonged symptoms after a COVID-19 infection.
Understanding the interplay between HIV and long COVID is crucial, as individuals with HIV are often already managing a complex health profile. While initial concerns centered on increased susceptibility to severe acute COVID-19, attention is shifting to the potential for a more protracted recovery and a greater burden of long-term symptoms in this population. This is particularly relevant given that approximately 39 million people globally are living with HIV, according to the Joint United Nations Programme on HIV/AIDS (UNAIDS) as of 2022.
HIV and Immune Dysfunction: A Potential Link to Long COVID
The connection between HIV and a potentially increased risk of long COVID likely stems from the impact of HIV on the immune system. Even with effective antiretroviral therapy (ART), which suppresses the virus to undetectable levels, some degree of immune dysregulation can persist. This chronic immune activation, a hallmark of HIV, may impair the body’s ability to effectively clear the SARS-CoV-2 virus and resolve the inflammatory response, potentially contributing to the development of long COVID symptoms.
Researchers are investigating several mechanisms that could explain this link. One hypothesis centers on the concept of “viral reservoirs” in HIV, where the virus remains dormant in certain tissues despite ART. Reactivation of these reservoirs during a COVID-19 infection could exacerbate immune dysfunction and prolong inflammation. Another area of investigation focuses on the potential for SARS-CoV-2 to disrupt the delicate balance of immune cells in individuals with HIV, leading to a prolonged and aberrant immune response.
What Symptoms are Being Reported?
Studies are beginning to identify specific long COVID symptoms that appear to be more prevalent among people living with HIV. Fatigue, cognitive dysfunction (“brain fog”), shortness of breath, and muscle aches are commonly reported, mirroring the broader range of long COVID symptoms experienced by the general population. Though, some research suggests that individuals with HIV may experience a higher incidence of neurological symptoms, such as headaches, dizziness, and difficulty concentrating.
A study published in Clinical Infectious Diseases in November 2023, for example, found that people with HIV were more likely to report persistent fatigue and neurocognitive symptoms compared to those without HIV after a COVID-19 infection . The study, which analyzed data from a large cohort of patients, likewise indicated that lower CD4 cell counts—a measure of immune function—were associated with a greater risk of developing long COVID.
Challenges in Research and Data Collection
Pinpointing the exact relationship between HIV and long COVID presents several challenges. One key issue is the heterogeneity of the HIV population. Factors such as duration of HIV infection, ART adherence, CD4 cell count, and the presence of other co-morbidities can all influence an individual’s immune response and susceptibility to long COVID.
many studies on long COVID have not specifically included detailed data on HIV status, making it difficult to draw definitive conclusions. Researchers are now actively working to address these gaps by conducting more targeted studies that specifically enroll and follow individuals with HIV who have been infected with SARS-CoV-2. These studies will be crucial for identifying risk factors, understanding underlying mechanisms, and developing effective interventions.
Implications for Clinical Care and Future Research
The emerging evidence linking HIV and long COVID has important implications for clinical care. Healthcare providers should be particularly vigilant in monitoring individuals with HIV for the development of long COVID symptoms after a COVID-19 infection. Early identification and management of these symptoms can help improve quality of life and prevent long-term disability.
Further research is needed to determine the optimal strategies for preventing and treating long COVID in people living with HIV. Potential interventions include immunomodulatory therapies, rehabilitation programs, and targeted symptom management. It’s also important to investigate whether adjusting ART regimens or incorporating additional immune-boosting strategies could help mitigate the risk of long COVID in this vulnerable population.
The National Institutes of Health (NIH) has launched the RECOVER Initiative, a large-scale research program aimed at understanding, preventing, and treating long COVID . This initiative includes several studies specifically focused on understanding the impact of underlying health conditions, including HIV, on the development and progression of long COVID.
As research continues, a clearer picture will emerge of the complex interplay between HIV, COVID-19, and long COVID. This knowledge will be essential for developing effective strategies to protect the health and well-being of individuals living with HIV in the face of this ongoing pandemic.
Disclaimer: This article provides general information and should not be considered medical advice. Individuals with HIV who have concerns about long COVID should consult with their healthcare provider for personalized guidance and treatment.
Have you or someone you know experienced long COVID after a COVID-19 infection? Share your experiences and thoughts in the comments below. And please, share this article with anyone who might uncover this information helpful.
